the devastating effects of relapsed or refractory aml
Published 6 years ago • 1.7K plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
1:50
histamine dihydrochloride and il-2 for aml: impacts for relapse risk and survival
-
3:21
studying the evolution of acute myeloid leukemia (aml) relapse
-
2:47
management of relapse following allohsct in patients with aml and mds
-
1:02
the impact of sequencing in aml
-
4:41
acute myeloid leukemia survival rate and outlook
-
2:07
updates in treatment options for patients with aml
-
2:23
the significance of variant allele frequency in patients with sf3b1-mutated mds
-
2:41
onvansertib and decitabine in relapsed/refractory aml
-
5:08
finding novel treatment options for relapsed/progressing aml
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
2:22
the treatment of relapsed/refractory chronic lymphocytic leukemia
-
2:49
the role of the immune system in the pathophysiology of mds
-
2:38
managing relapse in aml: the role of mrd
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:58
maintenance therapy strategies to reduce relapse in aml
-
1:47
improving the assessment of response in relapsed mm
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:17
the efficacy of olutasidenib in aml following venetoclax failure
-
1:38
an overview of the practical challenges in approaching r/r amyloidosis
-
6:24
gilteritinib in r/r aml